Pentedrone (NEP)
Pentedrone (NEP): Research Chemical Overview, Structure, and Legal Status
Pentedrone, sometimes referred to as NEP (N-Ethyl-Pentedrone), is a synthetic stimulant belonging to the cathinone class. Structurally similar to other substituted cathinones like mephedrone and alpha-PVP, Pentedrone has been studied in forensic chemistry and toxicology due to its potential psychostimulant effects.
It has appeared in both legitimate research contexts and illicit markets. However, Pentedrone is not approved for human or veterinary use and is intended for analytical, forensic, and scientific research only.
What is Pentedrone (NEP)?
Pentedrone is a beta-keto amphetamine, structurally related to cathinone—a naturally occurring stimulant found in the khat plant. It features a phenyl ring, pentyl side chain, and a keto group, contributing to its activity as a norepinephrine-dopamine reuptake inhibitor (NDRI).
-
IUPAC Name: 2-(Methylamino)-1-phenylpentan-1-one
-
Common Variant (NEP): N-Ethyl derivative of pentedrone
-
Molecular Formula: C12H17NO
-
Chemical Class: Synthetic cathinone, stimulant
-
Typical Form: Off-white crystalline powder
In its N-ethyl form (NEP), the substitution increases lipophilicity, which may affect onset and duration of action, although scientific studies remain limited.
Reported Effects (Anecdotal)
While clinical data is unavailable, anecdotal reports from research communities and laboratory case reviews describe effects similar to those of other cathinones:
-
Increased alertness and energy
-
Enhanced focus
-
Elevated mood or mild euphoria
-
Appetite suppression
-
Short-lived stimulant action
These effects vary based on dose, purity, and individual metabolism. There is no peer-reviewed evidence supporting safety, efficacy, or pharmacological tolerability in humans.
Risks and Safety Profile
Pentedrone and NEP are associated with a range of safety concerns common to synthetic stimulants. Without proper lab protocols, use can result in serious health and legal risks.
Potential risks include:
-
Cardiovascular strain (elevated heart rate, hypertension)
-
Anxiety or overstimulation
-
Insomnia or restlessness
-
Risk of neurotoxicity (unknown but suspected)
-
Compulsive redosing behavior
This compound must only be handled by qualified researchers using proper personal protective equipment (PPE) in controlled environments. It is not suitable for recreational or therapeutic use.
Legal Status of Pentedrone (NEP)
Due to its close similarity to other regulated cathinones, Pentedrone is controlled or restricted in many regions worldwide. Legal classification often applies to both the parent compound and its N-ethyl analogue (NEP).
-
United States: Not specifically scheduled, but may be regulated under the Federal Analog Act
-
United Kingdom: Controlled under the Psychoactive Substances Act (PSA)
-
Germany: Regulated under the NpSG (New Psychoactive Substances Act)
-
European Union: Subject to restrictions under member state drug control laws
-
Canada & Australia: Typically controlled under synthetic stimulant regulations
Legal status is subject to rapid change. Researchers must ensure compliance with all local, national, and international laws before acquiring or studying this substance.
For Research Use Only
Pentedrone (NEP) is provided for analytical, toxicological, and scientific research purposes only. It is not approved for human or veterinary consumption, and improper handling or use may lead to severe legal and health consequences.
Laboratories handling this compound must be licensed and follow all safety, storage, and disposal protocols in accordance with regional regulations.
Showing all 2 results